LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 56

Suchoptionen

  1. Artikel: Update on transfusion-related acute lung injury.

    Toy, Pearl

    Clinical advances in hematology & oncology : H&O

    2019  Band 17, Heft 7, Seite(n) 378–381

    Mesh-Begriff(e) Humans ; Transfusion-Related Acute Lung Injury/diagnosis ; Transfusion-Related Acute Lung Injury/epidemiology ; Transfusion-Related Acute Lung Injury/pathology ; Transfusion-Related Acute Lung Injury/therapy
    Sprache Englisch
    Erscheinungsdatum 2019-08-26
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2271951-9
    ISSN 1543-0790
    ISSN 1543-0790
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Antibodies associated with TRALI: differences in clinical relevance.

    Kopko, Patricia M / Bux, Jürgen / Toy, Pearl

    Transfusion

    2018  Band 59, Heft 3, Seite(n) 1147–1151

    Mesh-Begriff(e) Antibodies/immunology ; Blood Donors ; Female ; Humans ; Male ; Transfusion Reaction/immunology ; Transfusion-Related Acute Lung Injury/immunology
    Chemische Substanzen Antibodies
    Sprache Englisch
    Erscheinungsdatum 2018-12-13
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.15094
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Transfusion-related Acute Lung Injury: 36 Years of Progress (1985-2021).

    Toy, Pearl / Looney, Mark R / Popovsky, Mark / Palfi, Miodrag / Berlin, Gösta / Chapman, Catherine E / Bolton-Maggs, Paula / Matthay, Michael A

    Annals of the American Thoracic Society

    2022  Band 19, Heft 5, Seite(n) 705–712

    Abstract: The term transfusion-related acute lung injury (TRALI) was coined in 1985 to describe acute respiratory distress syndrome (ARDS) after transfusion, when another ARDS risk factor was absent; TRALI cases were mostly associated with donor leukocyte antibody. ...

    Abstract The term transfusion-related acute lung injury (TRALI) was coined in 1985 to describe acute respiratory distress syndrome (ARDS) after transfusion, when another ARDS risk factor was absent; TRALI cases were mostly associated with donor leukocyte antibody. In 2001, plasma from multiparous donors was implicated in TRALI in a randomized controlled trial in Sweden. In 2003 and in many years thereafter, the U.S. Food and Drug Administration reported that TRALI was the leading cause of death from transfusion in the United States. In 2003, the United Kingdom was the first among many countries to successfully reduce TRALI using male-predominant plasma. These successes are to be celebrated. Nevertheless, questions remain about the mechanisms of non-antibody TRALI, the role of blood products in the development of ARDS in patients receiving massive transfusion, the causes of unusual TRALI cases, and how to reduce inaccurate diagnoses of TRALI in clinical practice. Regarding the latter, a study in 2013-2015 at 169 U.S. hospitals found that many TRALI diagnoses did not meet clinical definitions. In 2019, a consensus panel established a more precise terminology for clinical diagnosis: TRALI type I and TRALI type II are cases where transfusion is the likely cause, and ARDS are cases where transfusion is not the likely cause. For accurate diagnosis using these clinical definitions, critical care or pulmonary expertise is needed to distinguish between permeability versus hydrostatic pulmonary edema, to determine whether an ARDS risk factor is present, and, if so, to determine whether respiratory function was stable within the 12 hours before transfusion.
    Mesh-Begriff(e) Blood Transfusion ; Humans ; Male ; Pulmonary Edema/etiology ; Respiratory Distress Syndrome/etiology ; Respiratory Distress Syndrome/therapy ; Transfusion Reaction/complications ; Transfusion-Related Acute Lung Injury/complications ; Transfusion-Related Acute Lung Injury/diagnosis
    Sprache Englisch
    Erscheinungsdatum 2022-01-19
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural
    ZDB-ID 2717461-X
    ISSN 2325-6621 ; 1943-5665 ; 2325-6621
    ISSN (online) 2325-6621 ; 1943-5665
    ISSN 2325-6621
    DOI 10.1513/AnnalsATS.202108-963CME
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Reply to concerns regarding dropping the term "possible TRALI".

    Toy, Pearl / Kleinman, Steven H / Looney, Mark R

    Transfusion

    2016  Band 56, Heft 9, Seite(n) 2394–2395

    Sprache Englisch
    Erscheinungsdatum 2016-09
    Erscheinungsland United States
    Dokumenttyp Letter
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.13734
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Proposed revised nomenclature for transfusion-related acute lung injury.

    Toy, Pearl / Kleinman, Steven H / Looney, Mark R

    Transfusion

    2017  Band 57, Heft 3, Seite(n) 709–713

    Abstract: A decade ago, definitions of "transfusionߚrelated acute lung injury (TRALI)" and "possible TRALI" were standardized for research and clinical diagnosis. Since then, evidence has confirmed that TRALI is often due to transfusion of white blood cell ... ...

    Abstract A decade ago, definitions of "transfusionߚrelated acute lung injury (TRALI)" and "possible TRALI" were standardized for research and clinical diagnosis. Since then, evidence has confirmed that TRALI is often due to transfusion of white blood cell antibodies to at-risk patients, and the term "TRALI, antibody mediated" is appropriate for such cases. Other TRALI cases are non-antibody mediated. Because specific, nonantibody transfusion factors have not yet been confirmed to cause TRALI in humans, the general term "TRALI, non-antibody mediated" is appropriate for such cases. In contrast, evidence is against possible TRALI being due to transfusion with the more likely cause of the acute respiratory distress syndrome (ARDS) being the alternative ARDS risk factor present in these patients. We propose to drop the misleading term "possible TRALI" and to rename this category of cases as "transfused ARDS." These nomenclature updates will more accurately categorize ARDS cases that develop after transfusion.
    Mesh-Begriff(e) Acute Lung Injury/blood ; Acute Lung Injury/classification ; Humans ; Respiratory Distress Syndrome, Adult/blood ; Respiratory Distress Syndrome, Adult/classification ; Risk Factors ; Transfusion Reaction/blood ; Transfusion Reaction/classification
    Sprache Englisch
    Erscheinungsdatum 2017-03
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.13944
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: An update of the transfusion-related acute lung injury (TRALI) definition.

    Vlaar, Alexander P J / Toy, Pearl / Fung, Mark / Looney, Mark R / Juffermans, Nicole P / Bux, Juergen / Bolton-Maggs, P / Peters, Anna L / Silliman, Christopher C / Kor, Daryl J / Kleinman, Steve

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

    2019  Band 26, Heft 4, Seite(n) 354–356

    Mesh-Begriff(e) Canada ; Delphi Technique ; Humans ; Respiratory Distress Syndrome, Adult/etiology ; Terminology as Topic ; Transfusion Reaction ; Transfusion-Related Acute Lung Injury
    Sprache Englisch
    Erscheinungsdatum 2019-06-12
    Erscheinungsland France
    Dokumenttyp Letter
    ZDB-ID 1204698-x
    ISSN 1953-8022 ; 1246-7820
    ISSN (online) 1953-8022
    ISSN 1246-7820
    DOI 10.1016/j.tracli.2019.05.007
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury.

    Sayah, David M / Looney, Mark R / Toy, Pearl

    Critical care clinics

    2012  Band 28, Heft 3, Seite(n) 363–72, v

    Abstract: Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. TRALI presents as acute lung injury (ALI) within 6 hours after blood product transfusion. Diagnosing TRALI requires a high index of suspicion, and the ... ...

    Abstract Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. TRALI presents as acute lung injury (ALI) within 6 hours after blood product transfusion. Diagnosing TRALI requires a high index of suspicion, and the exclusion of circulatory overload or other causes of ALI. The pathophysiology of TRALI is incompletely understood, but in part involves transfusion of certain anti-neutrophil antibodies, anti-HLA antibodies, or other bioactive substances, into susceptible recipients. Recent studies have identified both recipient and transfusion risk factors for the development of TRALI. This article describes these TRALI risk factors, as well as diagnosis, treatment and prevention strategies.
    Mesh-Begriff(e) Acute Lung Injury/epidemiology ; Acute Lung Injury/etiology ; Acute Lung Injury/physiopathology ; Acute Lung Injury/prevention & control ; Acute Lung Injury/therapy ; Blood Group Incompatibility ; Humans ; Incidence ; Risk Factors ; Transfusion Reaction
    Sprache Englisch
    Erscheinungsdatum 2012-06-19
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1006423-0
    ISSN 1557-8232 ; 0749-0704
    ISSN (online) 1557-8232
    ISSN 0749-0704
    DOI 10.1016/j.ccc.2012.04.001
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: TRALI--definition, mechanisms, incidence and clinical relevance.

    Toy, Pearl / Lowell, Clifford

    Best practice & research. Clinical anaesthesiology

    2007  Band 21, Heft 2, Seite(n) 183–193

    Abstract: Transfusion-related acute lung injury (TRALI) is defined as new acute lung injury (ALI) that occurs during or within six hours of transfusion, not explained by another ALl risk factor. Transfusion of part of one unit of any blood product can cause TRALI. ...

    Abstract Transfusion-related acute lung injury (TRALI) is defined as new acute lung injury (ALI) that occurs during or within six hours of transfusion, not explained by another ALl risk factor. Transfusion of part of one unit of any blood product can cause TRALI. The mechanism may include factors in unit(s) of blood, such as antibody and biologic response modifiers. In addition, yet to be described factors in a patient's illness may predispose to the condition. The current incidence is estimated to be 1 in 5000 units. Patients present with acute dyspnea, or froth in the endotracheal tube in intubated patients. Hypertension, hypotension, acute leukopenia have been described. Management is similar to that for ALI and is predominantly supportive. When TRALI is suspected, Blood banks should be notified to quarantine other components from the same donation. No special blood product is required for subsequent transfusion of a patient who has developed TRALI.
    Mesh-Begriff(e) Blood Donors ; Genetic Predisposition to Disease ; Humans ; Incidence ; Practice Guidelines as Topic ; Pulmonary Edema/epidemiology ; Pulmonary Edema/etiology ; Respiratory Distress Syndrome, Adult/epidemiology ; Respiratory Distress Syndrome, Adult/etiology ; Risk Assessment ; Risk Factors ; Transfusion Reaction
    Sprache Englisch
    Erscheinungsdatum 2007-07-03
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1499424-0
    ISSN 1521-6896
    ISSN 1521-6896
    DOI 10.1016/j.bpa.2007.01.003
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Eradicating hepatitis B virus: The critical role of preventing perinatal transmission.

    Stevens, Cladd E / Toy, Pearl / Kamili, Saleem / Taylor, Patricia E / Tong, Myron J / Xia, Guo-Liang / Vyas, Girish N

    Biologicals : journal of the International Association of Biological Standardization

    2017  Band 50, Seite(n) 3–19

    Abstract: Prevention of hepatitis B virus (HBV) transmission from infected mothers to their newborns is critical to HBV control and eventual eradication. Mother-to-child perinatal transmission causes the highest chronic carrier rate (>85%) with a high rate of ... ...

    Abstract Prevention of hepatitis B virus (HBV) transmission from infected mothers to their newborns is critical to HBV control and eventual eradication. Mother-to-child perinatal transmission causes the highest chronic carrier rate (>85%) with a high rate of subsequent chronic liver disease and hepatocellular carcinoma. This risk is reduced by 90% with HBV vaccine given along with hepatitis B immune globulin (HBIG) starting at birth. New analyses of our data from US trials of HBIG and HBV vaccine in high-risk infants revealed better efficacy with yeast-recombinant vaccine than plasma-derived vaccine, especially in preventing late onset infections, with evidence that vaccine prevented transmission of maternal HBV infection with the glycine to arginine mutation in surface antigen codon 145 (sG145R). Most late infections with sG145R were in vaccine non-responders, suggesting escape from HBIG rather than from vaccine-induced antibody. Our findings also help explain survey results from Taiwan following universal childhood immunization implemented in the mid-1980s. We conclude that current vaccines will remain effective against surface antigen mutants. Anti-viral drugs in high-risk pregnant women, in combination with newborn HBIG and vaccine, show promise for eliminating residual breakthrough neonatal infections, critical to meeting WHO 2030 goals and for eradicating HBV.
    Mesh-Begriff(e) Adult ; Female ; Hepatitis B/immunology ; Hepatitis B/transmission ; Hepatitis B/virology ; Hepatitis B Vaccines/immunology ; Hepatitis B Vaccines/therapeutic use ; Hepatitis B virus/drug effects ; Hepatitis B virus/immunology ; Hepatitis B virus/physiology ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical/prevention & control ; Pregnancy ; Pregnancy Complications, Infectious/immunology ; Pregnancy Complications, Infectious/prevention & control ; Pregnancy Complications, Infectious/virology
    Chemische Substanzen Hepatitis B Vaccines
    Sprache Englisch
    Erscheinungsdatum 2017-11
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1017370-5
    ISSN 1095-8320 ; 1045-1056
    ISSN (online) 1095-8320
    ISSN 1045-1056
    DOI 10.1016/j.biologicals.2017.08.008
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: A Clinical Trial to Detect Subclinical Transfusion-induced Lung Injury during Surgery.

    Feiner, John R / Gropper, Michael A / Toy, Pearl / Lieberman, Jeremy / Twiford, Jenifer / Weiskopf, Richard B

    Anesthesiology

    2015  Band 123, Heft 1, Seite(n) 126–135

    Abstract: Background: Transfusion-related acute lung injury incidence remains the leading cause of posttransfusion mortality. The etiology may be related to leukocyte antibodies or biologically active compounds in transfused plasma, injuring susceptible recipient' ...

    Abstract Background: Transfusion-related acute lung injury incidence remains the leading cause of posttransfusion mortality. The etiology may be related to leukocyte antibodies or biologically active compounds in transfused plasma, injuring susceptible recipient's lungs. The authors have hypothesized that transfusion could have less severe effects that are not always appreciated clinically and have shown subtly decreased pulmonary oxygen gas transfer in healthy volunteers after transfusion of fresh and 21-day stored erythrocytes. In this study, the authors tested the same hypothesis in surgical patients.
    Methods: Ninety-one patients undergoing elective major spine surgery with anticipated need for erythrocyte transfusion were randomly allocated to receive their first transfusion of erythrocytes as cell salvage (CS), washed stored, or unwashed stored. Clinicians were not blinded to group assignment. Pulmonary gas transfer and mechanics were measured 5 min before and 30 min after erythrocyte transfusion.
    Results: The primary outcome variable, gas transfer, as assessed by change of PaO2/FIO2, with erythrocyte transfusion was not significant in any group (mean ± SD; CS: 9 ± 59; washed: 10 ± 26; and unwashed: 15 ± 1) and did not differ among groups (P = 0.92). Pulmonary dead space (VD/VT) decreased with CS transfusion (-0.01 ± 0.04; P = 0.034) but did not change with other erythrocytes; the change from before to after erythrocyte transfusion did not differ among groups (-0.01 to +0.01; P = 0.28).
    Conclusions: The authors did not find impaired gas exchange as assessed by PaO2/FIO2 with transfused erythrocytes that did or did not contain nonautologous plasma. This clinical trial did not support the hypothesis of erythrocyte transfusion-induced gas exchange deficit that had been found in healthy volunteers.
    Mesh-Begriff(e) Acute Lung Injury/diagnosis ; Acute Lung Injury/etiology ; Adolescent ; Adult ; Aged ; Elective Surgical Procedures/adverse effects ; Elective Surgical Procedures/trends ; Erythrocyte Transfusion/adverse effects ; Erythrocyte Transfusion/trends ; Female ; Humans ; Intraoperative Complications/diagnosis ; Intraoperative Complications/etiology ; Male ; Middle Aged ; Pulmonary Gas Exchange/physiology ; Young Adult
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2015-07
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural
    ZDB-ID 269-0
    ISSN 1528-1175 ; 0003-3022
    ISSN (online) 1528-1175
    ISSN 0003-3022
    DOI 10.1097/ALN.0000000000000689
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang